Literature DB >> 16528612

Insights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domain.

J N Mark Glover1.   

Abstract

The C-terminal, BRCT repeats of BRCA1 are essential for the tumor suppressor function of this protein. Here we review structural and functional studies of this domain. Both repeats adopt similar folds and pack in an intimate, head-to-tail manner. The domain binds phosphorylated targets such as the DNA damage-associated kinase BACH1, with a specificity for pSer-X-X-Phe motifs. Structural studies reveal that the N-terminal repeat is responsible for pSer binding while a groove at the interface of the two repeats recognizes the Phe. Missense variants identified in breast cancer screening programs often disrupt these interactions and these molecular defects may lead to an increased cancer risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528612     DOI: 10.1007/s10689-005-2579-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  22 in total

1.  Direct DNA binding by Brca1.

Authors:  T T Paull; D Cortez; B Bowers; S J Elledge; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Authors:  Maria Rodriguez; Xiaochun Yu; Junjie Chen; Zhou Songyang
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

Review 3.  Interactions between BRCT repeats and phosphoproteins: tangled up in two.

Authors:  J N Mark Glover; R Scott Williams; Megan S Lee
Journal:  Trends Biochem Sci       Date:  2004-11       Impact factor: 13.807

4.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

Authors:  J Vallon-Christersson; C Cayanan; K Haraldsson; N Loman; J T Bergthorsson; K Brøndum-Nielsen; A M Gerdes; P Møller; U Kristoffersson; H Olsson; A Borg; A N Monteiro
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

5.  Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.

Authors:  R Scott Williams; J N Mark Glover
Journal:  J Biol Chem       Date:  2002-11-08       Impact factor: 5.157

6.  Functional assay for BRCA1: mutagenesis of the COOH-terminal region reveals critical residues for transcription activation.

Authors:  F Hayes; C Cayanan; D Barillà; A N Monteiro
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

7.  Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.

Authors:  Julie A Clapperton; Isaac A Manke; Drew M Lowery; Timmy Ho; Lesley F Haire; Michael B Yaffe; Stephen J Smerdon
Journal:  Nat Struct Mol Biol       Date:  2004-05-09       Impact factor: 15.369

8.  BRCT repeats as phosphopeptide-binding modules involved in protein targeting.

Authors:  Isaac A Manke; Drew M Lowery; Anhco Nguyen; Michael B Yaffe
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations.

Authors:  R Scott Williams; Daniel I Chasman; D Duong Hau; Benjamin Hui; Albert Y Lau; J N Mark Glover
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

View more
  22 in total

1.  Evidence for a structural relationship between BRCT domains and the helicase domains of the replication initiators encoded by the Polyomaviridae and Papillomaviridae families of DNA tumor viruses.

Authors:  Anuradha Kumar; Woo S Joo; Gretchen Meinke; Stephanie Moine; Elena N Naumova; Peter A Bullock
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

2.  The BRCA1-interacting protein Abraxas is required for genomic stability and tumor suppression.

Authors:  Andy Castillo; Atanu Paul; Baohua Sun; Ting Hsiang Huang; Yucai Wang; Stephanie A Yazinski; Jessica Tyler; Lei Li; M James You; Lee Zou; Jun Yao; Bin Wang
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

3.  Critical role of DNA checkpoints in mediating genotoxic-stress-induced filamentous growth in Candida albicans.

Authors:  Qing-Mei Shi; Yan-Ming Wang; Xin-De Zheng; Raymond Teck Ho Lee; Yue Wang
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

4.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

5.  Toward classification of BRCA1 missense variants using a biophysical approach.

Authors:  Pamela J E Rowling; Rebecca Cook; Laura S Itzhaki
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

6.  Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations.

Authors:  Ane Y Steffensen; Lars Jønson; Bent Ejlertsen; Anne-Marie Gerdes; Finn C Nielsen; Thomas V O Hansen
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

7.  Breast cancer and genetics.

Authors:  L Boeri; C Canzonieri; C Cagioni; F Ornati; C Danesino
Journal:  J Ultrasound       Date:  2011-10-20

8.  RAP80 responds to DNA damage induced by both ionizing radiation and UV irradiation and is phosphorylated at Ser 205.

Authors:  Jun Yan; Xiao-Ping Yang; Yong-Sik Kim; Anton M Jetten
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

Review 9.  RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites.

Authors:  Jun Yan; Anton M Jetten
Journal:  Cancer Lett       Date:  2008-06-11       Impact factor: 8.679

10.  Functional and structural analysis of C-terminal BRCA1 missense variants.

Authors:  Francisco Quiles; Juana Fernández-Rodríguez; Roberto Mosca; Lídia Feliubadaló; Eva Tornero; Joan Brunet; Ignacio Blanco; Gabriel Capellá; Miquel Àngel Pujana; Patrick Aloy; Alvaro Monteiro; Conxi Lázaro
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.